Lyell Competitors and Similar CompaniesClear all
Jounce Therapeutics's competitors and similar companies include Arvinas, NovoCure and Agenus.
 Arvinas Arvinas is a biopharmaceutical company focused on developing protein degradation therapeutics for cancers and other diseases. |  NovoCure NovoCure is a company engaged in the development, manufacture, and commercialization of solutions for the treatment of solid tumors. |  Agenus Agenus is an immuno-oncology company that focuses on the discovery and development of therapies for treating cancer. | ||
Founding Date | Founding Date 2013 | Founding Date N/A | Founding Date 2000 | Founding Date 1994 |
Type | Type Public | Type Public | Type Public | Type Public |
Tags | ||||
Locations | Locations Cambridge, US HQ | Locations New Haven, US HQ | Locations Lexington, US HQ Cambridge, GB Emeryville, US Berkeley, US Vacaville, US | |
Employees | Employees 1302% increase | Employees 13329% increase | Employees 1,488 | Employees 8174% decrease |
Valuation ($) | Valuation ($) 101.6 m | Valuation ($) 1.9 b | Valuation ($) 1.8 b | Valuation ($) 96.2 m |
Financial | ||||
Revenue (est.) | Revenue (est.) N/A | Revenue (est.) $262.6m (FY, 2025) | Revenue (est.) $655.4m (FY, 2025) | Revenue (est.) $114.2m (FY, 2025) |
Cost of goods | Cost of goods N/A | Cost of goods N/A | Cost of goods $166.9m (FY, 2025) | Cost of goods $1m (FY, 2025) |
Gross profit | Gross profit N/A | Gross profit N/A | Gross profit $488.5m (FY, 2025) | Gross profit $113.2m (FY, 2025) |
Net income | Net income ($50.9m) (FY, 2022) | Net income ($80.8m) (FY, 2025) | Net income ($136.2m) (FY, 2025) | Net income ($3.1m) (FY, 2025) |
Funding | ||||
Total funding raised | Total funding raised $ 103m | Total funding raised $ 111.6m | Total funding raised N/A | Total funding raised $ 171.1m |
For sources of this data, please see the company profile
View Company Profiles
Arvinas
HQ
New Haven, US
Employees
133↑ 29% increase
Arvinas is a biopharmaceutical company focused on developing protein degradation therapeutics for cancers and other diseases.
View companyNovoCure
HQ
Saint Helier, JE
Employees
1,488
NovoCure is a company engaged in the development, manufacture, and commercialization of solutions for the treatment of solid tumors.
View companyAgenus
HQ
Lexington, US
Employees
81
Agenus is an immuno-oncology company that focuses on the discovery and development of therapies for treating cancer.
View company